-
Fund Dashboard
- Holdings
PROFUND VP PHARMACEUTICALS
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
TARS Tarsus Pharmaceuticals, Inc. | 356.75 k | 6.44 k shares | 3.81 | Common equity | Long | USA |
PFE Pfizer Inc. | 353.19 k | 13.31 k shares | 3.77 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 342.60 k | 2.78 k shares | 3.66 | Common equity | Long | Ireland |
RPRX Royalty Pharma plc | 340.05 k | 13.33 k shares | 3.63 | Common equity | Long | UK |
BMY Bristol-Myers Squibb Company | 335.40 k | 5.93 k shares | 3.58 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 335.05 k | 3.37 k shares | 3.58 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 334.50 k | 4.01 k shares | 3.57 | Common equity | Long | USA |
JNJ Johnson & Johnson | 331.18 k | 2.29 k shares | 3.54 | Common equity | Long | USA |
VTRS Viatris Inc. | 328.01 k | 26.35 k shares | 3.50 | Common equity | Long | USA |
LLY Eli Lilly and Company | 325.78 k | 422.00 shares | 3.48 | Common equity | Long | USA |
ELAN Elanco Animal Health Incorporated | 324.66 k | 26.81 k shares | 3.47 | Common equity | Long | USA |
OGN Organon & Co. | 319.63 k | 21.42 k shares | 3.41 | Common equity | Long | USA |
PRGO Perrigo Company plc | 316.44 k | 12.31 k shares | 3.38 | Common equity | Long | Ireland |
ZTS Zoetis Inc. | 309.08 k | 1.90 k shares | 3.30 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 300.96 k | 11.27 k shares | 3.21 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 290.80 k | 3.44 k shares | 3.11 | Common equity | Long | USA |
CORT Corcept Therapeutics Incorporated | 281.78 k | 5.59 k shares | 3.01 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings, Inc. | 264.06 k | 7.67 k shares | 2.82 | Common equity | Long | USA |
HROW Harrow Health, Inc. | 255.72 k | 7.62 k shares | 2.73 | Common equity | Long | USA |
PBH Prestige Consumer Healthcare Inc. | 236.38 k | 3.03 k shares | 2.52 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals, Inc. | 189.61 k | 3.43 k shares | 2.03 | Common equity | Long | USA |
COLL Collegium Pharmaceutical, Inc. | 187.40 k | 6.54 k shares | 2.00 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals, Inc. | 183.39 k | 4.94 k shares | 1.96 | Common equity | Long | USA |
NMRA Neumora Therapeutics, Inc. Common Stock | 174.94 k | 16.50 k shares | 1.87 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 172.17 k | 8.98 k shares | 1.84 | Common equity | Long | USA |
WVE Wave Life Sciences Ltd. | 146.00 k | 11.80 k shares | 1.56 | Common equity | Long | Singapore |
PCRX Pacira BioSciences, Inc. | 143.98 k | 7.64 k shares | 1.54 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals, Inc. | 143.09 k | 3.96 k shares | 1.53 | Common equity | Long | USA |
Liquidia Corporation | 131.85 k | 11.21 k shares | 1.41 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals Incorporated | 127.72 k | 1.19 k shares | 1.36 | Common equity | Long | USA |
OCUL Ocular Therapeutix, Inc. | 123.07 k | 14.41 k shares | 1.31 | Common equity | Long | USA |
AMRX Amneal Pharmaceuticals, Inc. | 117.46 k | 14.83 k shares | 1.25 | Common equity | Long | USA |
INVA Innoviva, Inc. | 115.19 k | 6.64 k shares | 1.23 | Common equity | Long | USA |
CRMD CorMedix Inc. | 113.94 k | 14.07 k shares | 1.22 | Common equity | Long | USA |
EOLS Evolus, Inc. | 109.03 k | 9.88 k shares | 1.16 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals, Inc. | 85.44 k | 10.52 k shares | 0.91 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 77.44 k | 10.40 k shares | 0.83 | Common equity | Long | USA |
ESPR Esperion Therapeutics, Inc. | 77.18 k | 35.08 k shares | 0.82 | Common equity | Long | USA |
ZVRA Zevra Therapeutics, Inc. | 76.72 k | 9.20 k shares | 0.82 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 76.34 k | 3.39 k shares | 0.82 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 64.84 k | 4.92 k shares | 0.69 | Common equity | Long | USA |
MNMD Mind Medicine (MindMed) Inc. | 61.75 k | 8.87 k shares | 0.66 | Common equity | Long | Canada |
NUVB Nuvation Bio Inc. | 61.26 k | 23.03 k shares | 0.65 | Common equity | Long | USA |
Xeris Pharmaceuticals Inc | 56.87 k | 16.78 k shares | 0.61 | Common equity | Long | USA |
PAHC Phibro Animal Health Corporation | 50.69 k | 2.41 k shares | 0.54 | Common equity | Long | USA |
HSBC SECURITIES (USA), INC. B 4.2 , 1/01/2024 | 46.00 k | 46.00 k principal | 0.49 | Repurchase agreement | Long | USA |
SOCIETE' GENERALE C 4.3 , 1/01/2024 | 41.00 k | 41.00 k principal | 0.44 | Repurchase agreement | Long | USA |
NATWEST MARKETS PLC 4.33 , 1/01/2024 | 29.00 k | 29.00 k principal | 0.31 | Repurchase agreement | Long | USA |
CREDIT AGRICOLE CIB NY A 4.3 , 1/01/2024 | 24.00 k | 24.00 k principal | 0.26 | Repurchase agreement | Long | USA |
UMB FINANCIAL CORP. 4.15 , 1/01/2024 | 20.00 k | 20.00 k principal | 0.21 | Repurchase agreement | Long | USA |
ROYAL BANK OF CANADA 4.28 , 1/01/2024 | 16.00 k | 16.00 k principal | 0.17 | Repurchase agreement | Long | USA |
VPPH_SPSIPH_GOLDMAN
GOLDMAN SACHS GROUP, INC.
|
1.16 k | -10.00 other units | 0.01 | Equity derivative | Short | USA |
VPPH_SPSIPH_GOLDMAN
GOLDMAN SACHS GROUP, INC.
|
-3.09 k | 63.00 other units | -0.03 | Equity derivative | Long | USA |